Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 10,768 | 23,592 | 15,409 | 16,400 | 15,546 |
| Operating Income | -10,768 | -23,592 | -15,409 | -16,400 | -15,546 |
| Interest Expense | 0 | 0 | 0 | 2 | 11 |
| Other Income | 474 | 462 | 269 | 134 | 40 |
| Pre-tax Income | -10,294 | -23,130 | -15,140 | -16,268 | -15,517 |
| Net Income Continuous | -10,294 | -23,130 | -15,140 | -16,268 | -15,517 |
| Net Income | $-10,294 | $-23,130 | $-15,140 | $-16,268 | $-15,517 |
| EPS Basic Total Ops | -0.31 | -0.70 | -0.48 | -0.52 | -0.49 |
| EPS Basic Continuous Ops | -0.31 | -0.70 | -0.48 | -0.52 | -0.49 |
| EPS Diluted Total Ops | -0.31 | -0.70 | -0.48 | -0.52 | -0.49 |
| EPS Diluted Continuous Ops | -0.31 | -0.70 | -0.48 | -0.52 | -0.49 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.70 | -0.48 | -0.52 | -0.49 |
| EBITDA(a) | $-10,980 | $-23,596 | $-15,268 | $-16,184 | $-15,161 |